Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Sentiments and Price Targets for IBM March 2024

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Tokenized-security-technology
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

As of March 14, 2024, analysts have expressed a range of sentiments towards IBM, with some leaning towards bullishness and others towards bearishness. Over the past month, there has been 1 bullish rating, 0 somewhat bullish ratings, and a mix of other sentiments. Looking back over the last three months, the trend has seen fluctuations in ratings.

In terms of price targets, analysts have set an average target of $190.22 for IBM, with a high estimate of $220.00 and a low estimate of $143.00. This average target represents an 11.8% increase from the previous average.

Key analysts have recently made adjustments to their evaluations of IBM. For example, Wamsi Mohan from B of A Securities upgraded the rating to Buy with a price target of $220.00, while Toni Sacconaghi from Bernstein raised the rating to Market Perform with a price target of $186.00. Other analysts, such as Matthew Swanson from RBC Capital and Keith Bachman from BMO Capital, have also made adjustments to their ratings and price targets.

These changes in analyst recommendations and price targets reflect their responses to evolving market conditions and IBM’s performance.

IBM Stock Performance on March 14, 2024: Strong Showing Above 200-Day Moving Average

On March 14, 2024, IBM stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend over the long term, which is a positive sign for investors.

The price of IBM shares increased by $0.42 since the market last closed, representing a 0.21% rise. The stock opened at $196.96, which was $0.26 higher than its previous close. This indicates that there was strong buying interest in the stock at the opening bell, pushing the price higher right from the start of the trading day.

Overall, IBM stock showed positive momentum on March 14, 2024, with both the price and opening price showing gains. Investors who have been holding IBM shares may be pleased with the stock’s performance on that day.

IBM Stock Performance Shows Strong Growth in Net Income and EPS, Flat Total Revenue – March 14, 2024 Review

On March 14, 2024, IBM’s stock performance showed promising signs as the company reported strong financial results for the past year and the fourth quarter. According to data from CNN Money, IBM’s total revenue for the year stood at $61.86 billion, the same as the previous year, and for the fourth quarter, it was $17.38 billion, also holding flat since the last quarter. IBM managed to significantly increase its net income, with $7.50 billion for the year, marking a 357.44% increase from the previous year, and $3.29 billion for the fourth quarter, a 91.66% increase from the last quarter.

The impressive growth in net income was reflected in the earnings per share (EPS) as well, with IBM reporting an EPS of $8.14 for the year, a 352.86% increase from the previous year. However, the EPS for the fourth quarter remained flat at $3.55.

Overall, IBM’s financial performance on March 14, 2024, showcased a strong increase in net income and EPS, despite flat total revenue figures. Investors may have taken note of these positive results, leading to potential interest in IBM’s stock. It will be interesting to see how IBM’s stock performs in the coming days and whether the company can sustain its growth momentum.

Tags: IBM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Alternative Energy Markets and money (1)

Bright Green Corporation Announces 100 Million SolarPowered Generation Field for Drug Production Facility

TMUS stock news

Truist Securities Analyst Initiates Coverage on Illinois Tool Works with Buy Rating and 303 Price Target

Century Therapeutics Falls Short in Q4 Earnings Report

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com